Comment on "Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study"

Affiliations

Comment

Raghuraman M Sethuraman et al. Korean J Anesthesiol. 2025 Feb.

. 2025 Feb;78(1):85.

doi: 10.4097/kja.24684. Epub 2024 Nov 11.

¹ Department of Anesthesiology, Sree Balaji Medical College & Hospital, Bharath Institute of Higher Education and Research, Chennai, India.

No abstract available

Conflict of interest statement

Conflicts of Interest: No potential conflict of interest relevant to this article was reported.

Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study.
Kim JH, Nam JS, Seo WW, Joung KW, Chin JH, Kim WJ, Choi DK, Choi IC. Kim JH, et al. Korean J Anesthesiol. 2024 Oct;77(5):537-545. doi: 10.4097/kja.24138. Epub 2024 Jul 23. Korean J Anesthesiol. 2024. PMID: 39039823 Free PMC article.

1. Kim JH, Nam JS, Seo WW, Joung KW, Chin JH, Kim WJ, et al. Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study. Korean J Anesthesiol. 2024;77:537–45. doi: 10.4097/kja.24138. - DOI - PMC - PubMed
1. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, CONSORT Group Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308:2594–604. doi: 10.1001/jama.2012.87802. - DOI - PubMed
1. Hong B, Lee DK. Key insights and challeneges in noninferiority trials. Korean J Anesthesiol. 2024;77:423–31. doi: 10.4097/kja.23534. - DOI - PMC - PubMed